SHANGHAI, China, March 19, 2007 /Xinhua-PRNewswire/ -- WuXi PharmaTech, China's leading provider of pharmaceutical R&D outsourcing services announced today that it is a recipient of the 2006 Merck & Co., Inc. "Outstanding Strategic Collaboration Award" for its contribution to Merck's custom medicinal chemistry and process research chemistry and commitment to develop and grow capabilities to meet Merck's business needs. The award was presented to WuXi PharmaTech by Dr. John J. King, Senior Vice President, Research Planning and Integration, at Merck's New Jersey corporate headquarters on February 13, 2007.
| |
Merck's Supplier Recognition Forum is an annual event that recognizes suppliers that provide outstanding services to Merck. This year's award, with the theme, "Recognizing Supplier Contributions, Revealing Strategic Business Opportunities", seeks to recognize a select number of suppliers who have demonstrated unique and exemplary performance in support of Merck.
WuXi PharmaTech was one of the twelve companies selected from thousands of suppliers to be honored at this year's supplier recognition forum. "I am honored to, on behalf of WuXi PharmaTech's nearly 2,000 dedicated employees, accept this award. This award is symbolic of our tireless commitment to quality and value," commented Dr. Ge Li, Chairman and CEO of WuXi PharmaTech. "We are greatly benefited from the relationship with Merck & Co, Inc., and we have learned so much from Merck to set very high internal standard and compete in a very competitive industry," continued Dr. Li.
About WuXi PharmaTech Co., Ltd.
Founded in 2001, Shanghai-based WuXi PharmaTech is China's leading drug R&D service company. As a research-driven and customer-focused company, WuXi PharmaTech offers global pharmaceutical and biopharmaceutical companies a diverse, value-added, and fully integrated portfolio of outsourcing services ranging from discovery chemistry, and process chemistry to service biology, bioanalytical chemistry, and large scale GMP manufacturing. WuXi PharmaTech assists its global partners in shortening the cycle and lowering the cost of drug discovery and development by providing cost-effective and efficient outsourcing solutions that save our clients both time and money. Currently, our client list consists of 19 of the top 20 pharmaceutical, and 8 of the top 10 biopharmaceutical companies. For more information, please visit http://www.pharmatechs.com .
About Merck & Co., Inc.
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit http://www.merck.com .
For more information, please contact:
Sherry Shao
Tel: +86-21-5046-4002
Email:
PR@pharmatechs.com
CONTACT: Sherry Shao of WuXi, +86-21-5046-4002, or PR@pharmatechs.com
没有评论:
发表评论